Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer

@article{Beckmann2005HyperfractionatedAR,
  title={Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer},
  author={Gabriele K Beckmann and Florian Hoppe and Leo Pfreundner and Michael Flentje},
  journal={Head \& Neck},
  year={2005},
  volume={27}
}
The purpose of this study was to determine the feasibility and efficacy of hyperfractionated accelerated radiotherapy (HFRCB) combined with simultaneous chemotherapy with weekly cisplatin (CDDP) in locally advanced inoperable head and neck cancer. 
View on Wiley
sbccp.org.br
74 Citations
Highly Influential Citations
7
Background Citations
22
Methods Citations
6
Results Citations
3

74 Citations

Citation Type

Citation Type

Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinoma
The purpose of this report was to present the results of accelerated radiotherapy (RT) with concomitant weekly cisplatin in head and neck cancer.
Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience
We retrospectively examined the treatment efficacy and toxicity profile of intensity‐modulated radiotherapy (IMRT) plus concurrent weekly cisplatin chemotherapy in patients with locoregionally…
Early experience with a hybrid accelerated radiotherapy schedule for locally advanced head and neck cancer
TLDR
The aim was to determine feasibility and efficacy of a hybrid radiotherapy schedule in locally advanced head and neck cancer and to establish a protocol for selecting patients suitable for this treatment.
Concurrent chemoradiotherapy with weekly versus triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck: Comparative analysis
TLDR
A systemic review compared efficacy and safety of weekly vs triweekly cisplatin in locally advanced squamous cell carcinoma of the head and neck.
Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high‐dose cisplatin‐based chemoradiotherapy
This study evaluated ototoxicity in locally advanced head and neck cancer patients treated in the CONDOR study with docetaxel/cisplatin/5‐fluorouracil (TPF) followed by conventional radiotherapy with…
Assessing feasibility, compliance and toxicity of concomitant chemo‐radiotherapy in head and neck cancers in the Northern Territory: initial experience and challenges
TLDR
The purpose of this study is to assess feasibility, compliance and toxicity of CCRT in remote Australia.
Systemic therapy for squamous cell carcinoma of the head and neck.
Pretreatment risk stratification of feeding tube use in patients treated with intensity‐modulated radiotherapy for head and neck cancer
The purpose of this study was to establish a risk stratification model for feeding tube use in patients who undergo intensity‐modulated radiotherapy (IMRT) for head and neck cancers.
Impact of adding concomitant chemotherapy to hyperfractionated accelerated radiotherapy for advanced head-and-neck squamous cell carcinoma.
A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.
  • J. Medina, A. Rueda, +6 authors E. Alba
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 2006
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 34 REFERENCES
Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.
Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer.
TLDR
Combined treatment for advanced head and neck cancer is more efficacious and not more toxic than hyperfractionated irradiation alone.
Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: a randomized multicenter study.
TLDR
Concomitant CT offered improved disease control and survival in advanced head and neck cancer patients due to increased acute toxicity, more supportive care is demanded when CT is given simultaneously.
CONCURRENT CISPLATIN-BASED RADIOTHERAPY AND CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER
TLDR
Regimens of radiotherapy and chemotherapy that contain cisplatin improve the rates of survival and progression-free survival among women with locally advanced cervical cancer.
Cisplatin and radiotherapy in the management of locally advanced head and neck cancer.
  • A. Forastiere
  • Medicine
    International journal of radiation oncology, biology, physics
  • 1993
Who merits a neck dissection after definitive chemoradiotherapy for N2–N3 squamous cell head and neck cancer?
TLDR
Patients with N2–N3 disease treated with chemoradiotherapy are reviewed to identify predictors of a clinical complete response in the neck, pathologic complete response after ND (PCR‐neck), and regional failure.
Concomitant cisplatin and radiotherapy in a conventional and modified fractionation schedule in locally advanced head and neck cancer: a randomised phase II EORTC trial.
Hyperfractionated Radiation Therapy With or Without Concurrent Low-Dose Daily Cisplatin in Locally Advanced Squamous Cell Carcinoma of the Head and Neck: A Prospective Randomized Trial
TLDR
Hfx RT/chemotherapy offered significantly higher survival rates than Hfx RT alone and higher distant metastasis-free survival (DMFS), but there was no difference between the two treatment groups in the incidence of squamous cell carcinoma.
Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial.
  • J. Horiot, P. Bontemps, +10 authors L. Collette
  • Medicine
    Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
  • 1997
Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma.
TLDR
Adding weekly infusions of cisplatin to pelvic radiotherapy followed by hysterectomy significantly reduced the risk of disease recurrence and death in women with bulky stage IB cervical cancers.
...
1
2
3
4
...